Close

ACETO Corp (ACET) Unit Launches Generic Ditropan XL Tablets

Go back to ACETO Corp (ACET) Unit Launches Generic Ditropan XL Tablets

ACETO Subsidiary, Rising Pharmaceuticals, to Launch Oxybutynin Chloride Extended-Release Tablets, USP

November 14, 2016 9:45 AM EST

PORT WASHINGTON, N.Y., Nov. 14, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ: ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, is launching Oxybutynin Chloride Extended-Release Tablets, USP, an FDA-approved generic version of Janssen Pharmaceuticals, Inc.s Ditropan XL Tablets®.

According to IMS Health data, U.S. market sales for Oxybutynin Chloride Extended-Release Tablets, USP, which is used in the treatment of overactive bladder, were... More